Abhijit A. Patel, Ph.D.
Institution:
Yale University, New Haven, CTArea:
RNA, SplicingGoogle:
"Abhijit Patel"Mean distance: 8.94 | S | N | B | C | P |
Parents
Sign in to add mentor| Joan A. Steitz | grad student | 2002 | Yale | |
| (The splicing of U12 -type introns is a rate-limiting step in gene expression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim JW, Hafez N, Soliman HH, et al. (2020) Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors. Journal of Clinical Oncology. 38: 9065-9065 |
| Kole AJ, Park HS, Johnson SB, et al. (2019) Overall survival is improved when DCIS accompanies invasive breast cancer. Scientific Reports. 9: 9934 |
| Cheok S, Arnal-Estape A, Narayan A, et al. (2019) Cerebrospinal Fluid Biomarkers of Brain Metastasis Neurosurgery. 66 |
| Goldberg SB, Narayan A, Kole AJ, et al. (2018) Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Wu LR, Chen SX, Wu Y, et al. (2017) Multiplexed enrichment of rare DNA variants via sequence-selective and temperature-robust amplification. Nature Biomedical Engineering. 1: 714-723 |
| Henick BS, Goldberg SB, Narayan A, et al. (2017) Circulating tumor DNA (ctDNA) to monitor treatment response and progression in patients treated with tyrosine kinase inhibitors (TKIs) and immunotherapy for EGFR-mutant non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 35: e20652-e20652 |
| Goldberg S, Narayan A, Kole A, et al. (2017) Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA Annals of Oncology. 28: v478 |
| James ES, Narayan A, Stein S, et al. (2014) Measurement of circulating tumor DNA as a cancer biomarker in gastrointestinal malignancies using a novel next-generation sequencing method. Journal of Clinical Oncology. 32: 217-217 |
| Goldberg SB, Narayan A, Carriero NJ, et al. (2014) Detection of sensitizing and resistance EGFR mutations from circulating tumor DNA (ctDNA) in blood using multiplexed next-generation sequencing in patients with advanced EGFR-mutant lung adenocarcinoma. Journal of Clinical Oncology. 32: 8093-8093 |
| James ES, Narayan A, Carriero NJ, et al. (2014) Monitoring changes in circulating tumor DNA in gastrointestinal malignancies using a novel next-generation sequencing method. Journal of Clinical Oncology. 32: 3645-3645 |